Gérald Luc

Medicine · Health Sciences

50h-index15.1kcitations107works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(42), Diabetes, Cardiovascular Risks, and Lipoproteins(33), Cancer, Lipids, and Metabolism(13), Adipokines, Inflammation, and Metabolic Diseases(12), Cholesterol and Lipid Metabolism(11)

Publications107 total

Lipoprotein Oxidation and Atherosclerosis
2023· 3 cited
Abstract 15701: Pharmacodynamics of Alirocumab in Patients With Autosomal Dominant Hypercholesterolemia Associated With PCSK9 Gain-Of-Function or ApoB Loss-Of-Function Mutations: An Open-Label Extension Study
Circulation·2018
Epidemiology of out-of-hospital cardiac arrest: A French national incidence and mid-term survival rate study
Anaesthesia Critical Care & Pain Medicine·2018· 86 cited
Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?
European Journal of Human Genetics·2018· 23 citedOpen Access
Age discrimination in out-of-hospital cardiac arrest care: a case-control study
European Journal of Cardiovascular Nursing·2017· 22 citedOpen Access
The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients
Journal of clinical lipidology·2016· 20 cited
Characterization of Autosomal Dominant Hypercholesterolemia Caused by <i>PCSK9</i> Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody
Circulation Cardiovascular Genetics·2015· 109 citedOpen Access
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
New England Journal of Medicine·2015· 2.3k citedOpen Access
Abstract 17156: A Randomized Placebo-phase Clinical Trial With the Monoclonal Antibody Alirocumab Demonstrates Reductions in Low-density Lipoprotein Cholesterol in Patients With Proprotein Convertase Subtilisin/Kexin Type 9 Gain-of-Function Mutations
Circulation·2013
Long-term prognostic value of preprocedural adiponectin levels in patients undergoing percutaneous coronary intervention
International Journal of Cardiology·2013· 3 cited
Triglycerides and Risk for Atherosclerotic Disease
2013
Multiple Biomarkers for the Prediction of Ischemic Stroke
Arteriosclerosis Thrombosis and Vascular Biology·2013· 77 cited
Normal HDL–apo AI turnover and cholesterol enrichment of HDL subclasses in New Zealand rabbits with partial nephrectomy
Metabolism·2012· 8 cited
Lipoprotein(a) plasma levels and the risk of cancer
European Journal of Cancer Prevention·2012· 27 cited
Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with the<i>APOE</i>p.Leu167del Mutation
Human Mutation·2012· 127 citedOpen Access
Molecular and functional analysis of two new MTTP gene mutations in an atypical case of abetalipoproteinemia
Journal of Lipid Research·2012· 48 citedOpen Access
Adipocytokines and the risk of ischemic stroke: The PRIME Study
Annals of Neurology·2011· 61 citedOpen Access
Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liver
Naunyn-Schmiedeberg s Archives of Pharmacology·2011· 38 cited
Recommandations pour la prise en charge des hypercholestérolémies de l’enfant
La Presse Médicale·2011· 4 cited
Recommandations pour la prise en charge des hypercholestérolémies de l'enfant.
La Presse Médicale·2011
page 1 of 6Next →

Frequent Co-authors

Dominique Arveiler(35), Alun Evans(30), François Cambien(21), Philippe Amouyel(15), Jean‐Bernard Ruidavets(15), Odette Poirier(14), Jean Ferrières(14), Laurence Tiret(13), Pierre Ducimetière(12), Jean‐Marie Bard(8), Viviane Nicaud(8), Stefan-Martin Herrmann(7), Jean‐Charles Fruchart(7), Frank Kee(6), I. Juhan‐Vague(5), Bart Staels(5), Pedro Marques‐Vidal(5), Marianne Abifadel(4), Jean‐Pierre Rabès(4), Michel Krempf(4)